tirzepatide sleep apnea Improves in Patients With Obesity, Drugmaker Says Sleep Apnea: GLP-1 Drug Zepbound

Semaglutides effects on weight loss, inflammation, and pain The semaglutide group also experienced an average 10.5% decrease in body weight compared to only an average 2% decrease in the placebo group

Scarpino, A

10.1111/j.1523-5378.2010.00768.x 113 DobsonR.GiovannoniG

Mario Campana In findings from a small study presented at the AACE Annual Scientific and Clinical Conference, researchers compared data from 25 adults who underwent kidney transplantation and took a GLP-1 receptor agonist after the procedure with a group of adults who did not use a GLP-1 after transplantation

AI can assist with diagnosis, individualized care, treatment prediction, and recovery tracking

USA 119 , e2200960119 (2022)